The Fund Grade · free · no account needed
What grade does HGHAX get?
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-09-01
The Hartford Healthcare Fund Class A
#171 of 440 graded active funds · blend · large segment peer group
The point · specialist footprint
HGHAX puts more of its book behind proven specialists than 71% of graded funds.
Bottom 20%
Bottom 40%
Middle
● Top 40%
Top 20%
That has mattered: over the past 2.7 years, funds on this rung beat bottom-rung funds by about 3.8 points per quarter, and beat the S&P in 43% of fund-quarters versus their 22%. The evidence argues this fund earns its seat.
2,825 graded funds · 2.7 years of filings, measured as they were published · evidence, not advice
3 funds in the same segment carry an A — members see the names and what they charge. See the alternatives →
The grade scores this fund's specialist share — the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
Conviction exposure
29%
of the book in specialist-converged names
Late-stage weight
24.5%
of the book in Crowded or Fading names
Active share
96%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book — top names by stage · as of 2026-09-09
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
HGHAX earns a C grade, ranking 171 of 440 graded funds, with only 29% specialist backing. The most striking concern is that ISRG, EW, and HCA are all Fading, meaning proven specialists are actively leaving those positions. ABT, DHR, and VRTX offer some early-stage interest, but higher-graded peers in this segment exist and may be worth comparing.
→ Watch the combined Fading weight in ISRG, EW, and HCA closely, as specialist exits there signal weakening conviction.
→ Compare this fund against the three higher-graded healthcare segment peers before adding new money, given the C grade.
Support leaving these positions
Same family, higher grade
Read from today's disclosed book. Evidence, not advice.
The evidence base updates this week.
The specialists — not the whales — are already positioned for what comes next. Stop finding out last.
Create your free accountNo card required · open the feed in 30 seconds